 |
Articles: Regulatory Issues |
BTG Collaborator Onyx Gains Approval to Progress Oncology Compound into Clinical Development
BTG, 08/18/09
Free full text
Chugai Files NDA for a Renal Anemia Agent R744
Chugai Pharmaceutical Co., 08/17/09
Free full text
Array BioPharma Advances Its Lead MEK Inhibitor into Cancer
Array BioPharma, 08/14/09
Free full text
Mylan Pharmaceuticals Receives Final FDA Report and Reaffirms Its 48-Year Exemplary Record of Quality
Mylan, 08/14/09 More than 35,000 cartons of albuterol sulfate stolen
American Pharmacists Association, 08/14/09
Free full text
Bristol-Myers Squibb Announces Expiration of Hart-Scott-Rodino Review Period for Acquisition of Medarex, Inc.
Bristol Myers-Squibb Company, 08/13/09
Free full text
Wyeth Provides Regulatory Update on Prevnar 13 in the United States
Wyeth, 08/12/09
Free full text
Allos Therapeutics Announces FDA Advisory Committee to Review Pralatrexate for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma
Allos Therapeutics, 08/11/09
Free full text
Watson Announces Limited Recall Of Fentanyl Transdermal System
Watson Pharmaceuticals, 08/10/09
Free full text
PhRMA Statement of Support for Introduction of the Customs
Facilitation and Trade Enforcement Reauthorization Act of 2009
PhRMA, 08/10/09
Free full text
Where is Industry Getting it Wrong? A Review of Quality Concerns Raised at Day 120 by the Committee for Medicinal Products for Human Use during European Centralised Marketing Authorisation Submissions for Chemical Entity Medicinal Products
Journal of Pharmacy and Pharmaceutical Sciences, 08/10/09
Free full text
Watson Pharmaceuticals and Arrow Group Receive FTC Second Request
Watson Pharmaceuticals, 08/07/09
Free full text
Teva Announces Appeals Court Ruling Affirming Invalidation Of Yasmin Patent
Teva Pharmaceutical Industries, 08/06/09
Free full text
Regulatory update: mepolizumab for the treatment of hypereosinophilic syndrome
GlaxoSmithKline, 08/05/09
Free full text
Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor Blockers
Amgen, 08/05/09
Free full text
Biopure Files Voluntary Petition for Relief Under Chapter 11 of the United States Bankruptcy Code
BioPure, 08/04/09
Free full text
Biopure Corporation Receives Notice of Delisting from Nasdaq
BioPure, 08/04/09
Free full text
Biopure Receives Notices About Nasdaq Listing Compliance
BioPure, 08/04/09
Free full text
Biopure Receives Notice of Nasdaq Delisting
BioPure, 08/04/09
Free full text
Biopure Receives Extension of Time to Regain NASDAQ Listing Compliance
BioPure, 08/04/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
